Tripos, Inc. - TRPS- Profile

Tripos, Inc.. The Group's principal activity is to deliver chemistry products and services to pharmaceutical, agrochemical and biotechnology industries. The Group operates in two segments. Discovery Informatics Segment: Designs and sells software suites that provide computer-aided molecular modelling and visualization, visual screening, combinatorial library design, data storage and analysis. Discovery Research Segment: Provides drug discovery services to pharmaceutical and biotechnology companies. The pharmaceutical clients include Aventis, Bayer, Bristol-Myers Squibb, Pfizer and Schering AG. The biotechnology clients include Biovitrum, Chronogen and Critical Therapeutics. The Group has operations in the United States, Europe, Germany, France and Pacific Rim. On 05-Jan-2005, the group acquired Optive Research Inc. Discovery Informatics accouonted for 51% of 2005 revenues and Discovery Research, 49%